About
Encoded Therapeutics develops one-time, disease-modifying gene therapies for pediatric central nervous system disorders, leveraging a cell-selective targeting and regulation platform. The company’s technology delivers unprecedented gene specificity and cell selectivity, enabling precise control of therapeutic transgene expression across any delivery system. This flexibility allows Encoded to shape target cell function and expand its therapeutic reach beyond CNS indications. By combining cutting-edge gene-editing precision with versatile delivery compatibility, Encoded positions itself as a leader in next-generation gene therapy innovation.
